Scientists test lab method to predict which chemo works best
NCT ID NCT04263181
Summary
This study aims to see if testing cancer cells in a lab dish can predict how well a patient will respond to chemotherapy. Researchers will collect blood samples from 80 adults with acute myeloid leukemia or myelodysplastic syndrome who are already scheduled to receive standard chemotherapy. The goal is to learn if lab results match real-world treatment outcomes, which could help guide future treatment choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.